Evaluation of the Clinical Findings and Glycemic Parameters in Patients Newly Diagnosed with Diabetes Mellitus After Being Infected with Coronavirus Disease-2019

OpenAlex İngilizce

Objective: The aim of this study was to analyze patients newly diagnosed with diabetes mellitus (DM) after coronavirus disease-2019 (COVID-19) infection and compare them with type 2 DM patients in terms of clinical findings and glycemic parameters.Method: This retrospective case-control study was conducted with patients with post-covid DM (PCDM) and newly diagnosed type 2 DM.Results: Fifty eight patients with PCDM and 57 patients with type 2 DM were included in the study.While 73 of the subjects were male, the mean age of the all subjects was 49.1 ± 12 years.The two groups were similar in terms of age, gender distribution, frequency of smoking and family history of DM, and mean body mass index (p > 0.05).Dry mouth, polyuria, polydipsia, and weight loss were more common in patients with type 2 DM, whereas fatigue was more common in patients with PCDM (p < 0.05).Serum creatinine levels were higher in patients with PCDM than in those with type 2 DM (p < 0.05), whereas glycosylated hemoglobin A1c, C-peptide, alanine transaminase, aspartate transaminase, lipid levels and microalbumin/creatinine ratio in spot urine were not different between the two groups (p > 0.05).One of the microvascular complications, neuropathy, was more common in patients with type 2 DM (p < 0.05).The frequency occurrence of diabetic ketoacidosis at the time of diagnosis of DM was similar in the groups (p > 0.05). Conclusion:In this study, PCDM patients were found to be different from type 2 DM in terms of symptoms and signs, but very similar to type 2 DM patients in terms of metabolic parameters.